Guard Therapeutics elects Tobias Agervald, David Bejker, Gunilla Ekström, Alexander Oker-Blom to board, reappoints Johan Bygge as chair

PUBT · 2d ago
Guard Therapeutics elects Tobias Agervald, David Bejker, Gunilla Ekström, Alexander Oker-Blom to board, reappoints Johan Bygge as chair
  • Guard Therapeutics elected four new directors, conditional on closing its reverse takeover of Disruptive Pharma around July 27, 2026.
  • Tobias Agervald, David Bejker, Gunilla Ekström, Alexander Oker-Blom joined the board; Johan Bygge was re-elected chair.
  • Johan Bygge, Göran Forsberg retained board seats; the company also disclosed Agervald as chief executive.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guard Therapeutics International AB (publ) published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.